Of note, CXCL5, CXCL8 and CCL25, which correspond to the chemokine antibodies representing the COVID-19 hospitalization signature, were not significantly different between mild and severe hospitalized COVID-19 convalescents in the Milan cohort (Fig. 3b). The gene discussed is CXCL8; the disease is COVID-19.